Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
Lucia Silvestrini, Norhan Belhaj, Lucia Comez, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Science Translational Medicine (2022) Vol. 15, Iss. 678
Open Access | Times Cited: 107
Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding
H. T. Henry Chan, Marc A. Moesser, Rebecca K. Walters, et al.
Chemical Science (2021) Vol. 12, Iss. 41, pp. 13686-13703
Open Access | Times Cited: 74
Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 67
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor
Nashaat T. Nashed, Annie Aniana, Rodolfo Ghirlando, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 44
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
Lara Alzyoud, Mohammad A. Ghattas, Noor Atatreh
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2463-2478
Open Access | Times Cited: 42
Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8792-8792
Open Access | Times Cited: 13
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 10
Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity
Ilaria Iacobucci, Irene Cipollone, Flora Cozzolino, et al.
International Journal of Biological Macromolecules (2025), pp. 139590-139590
Closed Access | Times Cited: 1
Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2
Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemistry (2025)
Closed Access | Times Cited: 1
An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
Fangfang Yan, Feng Gao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4868-4883
Open Access | Times Cited: 49
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Zheng Yao Low, Ashley Jia Wen Yip, Sunil K. Lal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 2, pp. 166294-166294
Open Access | Times Cited: 42
Phytochemicals in Drug Discovery - A Confluence of Tradition and Innovation
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
(2024)
Open Access | Times Cited: 7
Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain
Nashaat T. Nashed, Daniel W. Kneller, Leighton Coates, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 24
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor
Alice Romagnoli, Mattia D’Agostino, Eleonora Pavoni, et al.
Nano Today (2022) Vol. 48, pp. 101729-101729
Open Access | Times Cited: 23
Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by Molecular Dynamics Simulations
Meet Parmar, Ritik Thumar, Bhumi Patel, et al.
Structural Chemistry (2022) Vol. 34, Iss. 4, pp. 1309-1326
Open Access | Times Cited: 21
SARS-COV-2 Mpro conformational changes induced by covalently bound ligands
Gláucio Monteiro Ferreira, Thales Kronenberger, Arun Kumar Tonduru, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12347-12357
Open Access | Times Cited: 24
Dynamic allostery highlights the evolutionary differences between the CoV-1 and CoV-2 main proteases
Paul Campitelli, Lu Jin, S. Banu Ozkan
Biophysical Journal (2022) Vol. 121, Iss. 8, pp. 1483-1492
Open Access | Times Cited: 17
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
Alessandro Paciaroni, Valeria Libera, Francesca Ripanti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6062-6062
Open Access | Times Cited: 11
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 608-608
Open Access | Times Cited: 11
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
Jimena Pérez‐Vargas, L.J. Worrall, Andrea Olmstead, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 10
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
Norman Tran, Sathish Dasari, Sarah Barwell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding
Van Ngoc Thuy La, Lulu Kang, David D. L. Minh
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
<i>In Silico</i> Inhibitory Potential of Isolated Molecules of <i>Scoparia dulcis</i> L. (Scrophulariaceae) on SARS-CoV-2 Main Protease M<sup>pro</sup>
Moussa Ouédraogo, Windbedema Prisca Ouedraogo, Hermann W. Yameogo, et al.
Pharmacology & Pharmacy (2025) Vol. 16, Iss. 02, pp. 31-51
Open Access
The Efficiency of High-Throughput Screening (HTS) and in-silico data analysis during medical emergencies: identification of effective antiviral 3CLpro inhibitors.
Debora Zian, Daniela Iaconis, S. Nenci, et al.
Antiviral Research (2025), pp. 106119-106119
Open Access
SARS‐CoV‐2 Mpro Dihedral Angles Reveal Allosteric Signaling
Daniel J. Evans, Samreen Sheraz, Albert Y. Lau
Proteins Structure Function and Bioinformatics (2025)
Closed Access
Page 1 - Next Page

Scroll to top